Journal of the Association of Nurses in AIDS Care
Volume 18, Issue 1, Supplement , Pages S17-S22 , January 2007

Strategies for Improving Patient Adherence to Therapy and Long-Term Patient Outcomes

  • Anne M. Battaglioli-DeNero, RN, BSN, ACRN

      Affiliations

    • Anne M. Battaglioli-DeNero, RN, BSN, ACRN, is an HIV nurse specialist/consultant in Schenectady, New York.

References 

  1. Bangsberg DR, Perry S, Charlebois ED, Clark RA, Robertson M, Zolopa AR, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15:1181–1183
  2. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwicki B, et al. Patient Care & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG) Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care. 2000;12:255–266
  3. Chesney M. Adherence to HAART regimens. AIDS Patient Care and STDs. 2003;17:169–177
  4. Delgado J, Heath KV, Yip B, Marion S, Alfonso V, Montaner JSG, et al. Highly active antiretroviral therapy: Physician experience and enhanced adherence to prescription refill. Antiviral Therapy. 2003;8:471–478
  5. Golin CE, Earp J, Tien H-C, Stewart P, Porter C, Howie L. A 2-arm, randomized, controlled trial of a motivational interviewing–based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. Journal of Acquired Immune Deficiency Syndromes. 2006;42:42–51
  6. The Kaiser Commission on Medicaid and the Uninsured. (2006). The uninsured and their access to health care fact sheet. Retrieved April 11, 2006, from www.kff.org/uninsured
  7. Kalichman SC, Cherry J, Cain D. Nurse-delivered antiretroviral treatment adherence intervention for people with low literacy skills and living with HIV/AIDS. The Journal of the Association of Nurses in AIDS Care. 2005;16:3–15
  8. Kerr T, Palepu A, Barnes G, Walsh J, Hogg R, Montaner J, et al. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver. Antiviral Therapy. 2004;9:407–414
  9. Lichtenstein KA. Redefining lipodystrophy syndrome: Risks and impact on clinical decision making. Journal of Acquired Immune Deficiency Syndromes. 2005;39:395–400
  10. Milam J, Richardson JL, McCutchan A, Stoyanoff S, Weiss J, Kemper C, et al. Effect of a brief antiretroviral adherence intervention delivered by HIV care providers. Journal of Acquired Immune Deficiency Syndromes. 2005;40:356–363
  11. Mobius U, Lubach-Ruitman M, Castro-Frenzel B, Stoll M, Esser S, Voigt E, et al. Switching to atazanavir improves metabolic disorders in antiretroviral-experienced patients with severe hyperlipidemia. Journal of Acquired Immune Deficiency Syndromes. 2005;39:174–180
  12. Murri R, Antinori A, Ammassari A, Nappa S, Orofino G, Abrescia N. Physician estimates of adherence and the patient-physician relationship as a setting to improve adherence to antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes. 2002;31(Suppl. 3):S158–S162
  13. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine. 2000;133:21–30
  14. Read T, Mijch A, Fairley CK. Adherence to antiretroviral therapy: Are we doing enough?. Internal Medicine Journal. 2003;33:254–256
  15. Reiter GS, Stewart KE, Wojtusik L, Hewitt R, Segal-Maurer S, Johnson M, et al. Elements of success in HIV clinical care: Multiple interventions that promote adherence. Topics in HIV Medicine. 2000;8:21–30
  16. Tucker JS, Orlando M, Burnam MA, Sherbourne CD, Kung FY, Gifford AL. Psychosocial mediators of antiretroviral nonadherence in HIV-positive adults with substance use and mental health problems. Health Psychology. 2004;23:363–370
  17. U.S. Census Bureau. Income, poverty, and health insurance coverage in the United States: 2004. Washington, DC: Author; 2005;
  18. U.S. Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Washington, DC: Author; 2005;
  19. Walmsley S, Bernstein B, King M, Arribas J, Beall G, Ruane P, et al. Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection. The New England Journal of Medicine. 2002;346:2039–2046
  20. Weiser SD, Wolfe WR, Bangsberg DR. The HIV epidemic among individuals with mental illness in the United States. Current HIV/AIDS Reports. 2004;1:186–192

PII: S1055-3290(06)00316-5

doi: 10.1016/j.jana.2006.11.020

Journal of the Association of Nurses in AIDS Care
Volume 18, Issue 1, Supplement , Pages S17-S22 , January 2007

Article Tools

* Image Usage & Resolution